Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomized, Observer-blind, Multicenter Clinical Trial
© 2020 Lippincott Williams and Wilkins. All rights reserved. Background: Vaccination against seasonal influenza is recommended for all children with a history of medical conditions placing them at increased risk of influenza-associated complications. The immunogenicity and efficacy of conventional i...
Saved in:
Main Authors: | Susanna Esposito, John Fling, Kulkanya Chokephaibulkit, Marianne De Bruijn, Janine Oberye, Bin Zhang, Jeanique Vossen, Esther Heijnen, Igor Smolenov |
---|---|
Other Authors: | Janssen Vaccines & Prevention B.V. |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/58320 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Repeated exposure to an MF-59 adjuvanted quadrivalent subunit influenza vaccine (aQIV) in children: Results of two revaccination studies
by: Timo Vesikari, et al.
Published: (2020) -
Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study
by: Jiří Beran, et al.
Published: (2022) -
Safety and immunogenicity of MF59-adjuvanted cell culture-derived A/H5N1 subunit influenza virus vaccine: Dose-finding clinical trials in adults and the elderly
by: Sharon E. Frey, et al.
Published: (2020) -
Safety, Tolerability and Immunogenicity of an MF59-adjuvanted, Cell Culture-derived, A/H5N1, Subunit Influenza Virus Vaccine: Results From a Dose-finding Clinical Trial in Healthy Pediatric Subjects
by: Pornthep Chanthavanich, et al.
Published: (2020) -
A Prospective Immunogenicity Study of a Quadrivalent Inactivated Influenza Vaccine among Persons with HIV with Different Levels of CD4 Cell Count
by: Satanon S.
Published: (2023)